Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I - Immunohistochemical study

Pituitary

Volumn 5, Issue 4, 2002, Pages 221-223

  Ohta, S ^a   Nishizawa, Shigeru ^a   Oki, Y ^a   Yokoyama, T ^a   Namba, H ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cushing's disease; Prohormone convertase; Silent corticotroph cell adenoma

Indexed keywords

CORTICOTROPIN; FURIN; HORMONE PRECURSOR; PROOPIOMELANOCORTIN;

ADULT; AGED; ARTICLE; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSHING DISEASE; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SYMPTOMATOLOGY; TUMOR CLASSIFICATION;

ADENOMA; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; CUSHING SYNDROME; FEMALE; FURIN; HUMANS; HYDROCORTISONE; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PITUITARY NEOPLASMS; PRO-OPIOMELANOCORTIN; SUBTILISINS;

EID: 0141838780     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025321731790     Document Type: Article

References (13)

1. Ueyama T, Tamaki N, Kondoh T, Kurata H. Large and invasive silent corticotroph-cell adenoma with elevated serum ACTH: A case report. Surgical Neurology 1998;50:30-31.
2. Horvarth E, Kovacs K, Killinger DW, Smyth HS, Platts ME, Singer W. Silent scorticotropic adenomas of the human pituitary gland. Am J Pathol 1980;98:617-638.
3. Lloyd RV, Fields K, Jin L, Horvath E, Kovacs K. Analysis of endocrine active and clinically silent corticotropic pituitary adenomas by in situ hybridization. Am J Pathol 1990;137:479-488.
4. Black PM, Hsu DW, Klibanski A, Kliman B, Jameson JL, Ridgway EC, Hedley-Whyte ET, Zervas NT. Hormone production in clinically nonfunctioning pituitary adenomas. Journal of Neurosurgery 1987-166:244-250.
5. Reincke M, Allolio B, Saeger W, Kaulen D, Winkelmann W. A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing's disease. Journal of Clinical Endocrinology and Metabolism 1987;65:1296-1300.
6. Takumi I, Steiner DF, Sanno N, Teramoto A, Osamura RY. Localization of prohormone convertases 1/3 and 2 in the human pituitary gland and pituitary adenomas: Analysis by immunohistochemistry, immunoelectron microscopy, and laser scanning microscopy. Modern Pathology 1998;11:232-238.
7. Lloyd RV, Long Jin, Qian X, Scheithauer BW, Young WF Jr, Davis DH. Analysis of the chromogranin A post-translational product pancreatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries. American Journal of Pathology 1995;146:1188-1198.
8. Scopsi L, Gullo M, Rilke F, Martin S, Steiner DF. Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: Their use as markers of neuroendocrine differentiation. Journal of Clinical Endocrinology and Metabolism 1995;80:294-301.
9. Nishizawa S, Oki Y, Ohta S, Yokota N, Yokoyama T, Uemura K. What can predict postoperative "endocrinological cure" in Cushing's disease. Neurosurgery 1999;45:239-244.
10. Raff H, Findling JW. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clinical Chemistry 1989;35:596-600.
11. Ohta S, Koide M, Tokuyama T, Yokota N, Nishizawa S, Namba H. Cdc6 expression as a marker of proliferative activity in brain tumors. Oncol Rep 2001;8:1063-1066.
12. Horvarth E, Kovacs K, Lloyd R. Pars intermedia of the human pituitary revisited: Morphological aspects and frequency of hyperplasia of POMC-peptide immunoreactive cells. Endocr Pathol 1999;101:55-64.
13. Scheithauer BW, Jaap AJ, Horvath E, Kovacs K, Lloyd RV, Meyer FB, Laws Jr ER, Young Jr WF. Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery 2000;47:723-729, discussion 729-730.